Health and Healthcare
Merck (MRK): People Won't Even Buy Drugs
Published:
Last Updated:
So much fore feeling better in a bad economy.
Merck (MRK) offered lackluster guidance for next year and the stock is off before the open.
According to Reuters, "Merck said it expected earnings, excluding special items, of $3.15 to $3.30 per share. Analysts polled by Reuters Estimates were expecting $3.52, on average."
Get well soon.
Douglas A. McIntyre
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.